Clinical boundary Schedule I in the U.S. Serious cardiac risk Not FDA-approved No dosing or referrals Schedule I · cardiac risk Not FDA-approved · no referrals

Standards

Editorial standards

Source weighting, evidence confidence, medical boundaries, cultural limits, corrections, and conflicts of interest.

Source weighting

Highest weight

Primary law, agency records, trial registries, peer-reviewed papers, and official public records.

Context

Serious journalism, institutional reports, books, interviews, documentaries, and conference material.

Claims

Company releases, clinic pages, social posts, podcasts, newsletters, and marketing material.

Cultural sources

Public Gabonese, Bwiti-linked, conservation, stewardship, and community-engagement material, handled with explicit limits.

Evidence language

Medical and legal boundaries

This is not medical advice or legal advice. Ibogaine remains Schedule I federally in the United States, is not FDA-approved as a treatment, and carries serious cardiac and interaction risks.

Cultural boundaries

Public history, terminology, conservation, access, benefit-sharing, and published interviews can be cited and compared. Initiation instructions, lineage-held ceremonial songs or chants, private ritual sequences, sacred designs, dosing instructions, and claims about Bwiti authority belong with authorized holders.

Corrections

Corrections change the public page, preserve the source trail when possible, and appear in the changes feed when they affect interpretation.